Biologics Market Share

Statistics for the 2023 & 2024 Biologics market share, created by Mordor Intelligenceā„¢ Industry Reports. Biologics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Biologics Industry

The biologics industry is moderately competitive and consists of several major players. Biologic companies are implementing specific strategic initiatives such as mergers, new product launches, acquisitions, and partnerships that help them strengthen their market positions. These companies have made substantial capital investments in the research and development of biologics, as the cost of biologics is relatively high. Some top biologics companies include Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Abbvie Inc., and F. Hoffmann-La Roche AG.

Biologics Market Leaders

  1. Amgen, Inc.

  2. Eli Lilly and Company

  3. GlaxoSmithKline PLC

  4. Abbvie Inc.

  5. F. Hoffmann- La Roche AG

*Disclaimer: Major Players sorted in no particular order

Biologics Market Concentration

Biologics Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)